(Press-News.org) Virginia Tech researchers discovered an indication hidden in the brain that may help doctors identify children suffering from a rare genetic disease earlier. Their findings were published recently in EMBO Molecular Medicine.
Leigh syndrome is a severe neurological disorder that affects the mitochondria, which are energy factories found in almost all the cells of the body. This disease typically appears in infancy and can progress rapidly, leading to limited treatment options and poor survival rates.
Prenatal tests for mitochondrial disorders like Leigh syndrome are not commonly administered.
“If there's not any real sign that you have something wrong with you at birth, they're not going to recommend genetic testing or genetic counseling,” said Alicia Pickrell, associate professor in the School of Neuroscience.
Without screening, children with Leigh syndrome appear to develop normally until 9 or 10 months old, when they start to display symptoms and quickly decline.
However, a recent clinical study from the Children's Hospital of Philadelphia showed that early signs of neurodevelopmental delay often can be seen before the disease starts to impact a patient’s motor and respiratory functions.
When they learned about the early signs, Pickrell and her collaborators saw a way to help.
“The study is saying that these mutations don’t impact these patients out of the blue. These children were born with them,” Pickrell said.
Maybe, Pickrell said, we haven't used the right tools or looked at the right areas in the brain. Which means maybe there’s a chance people with this disease could be identified — and someday treated — earlier.
Working with Paul Morton, assistant professor in the Virginia-Maryland College of Veterinary Medicine, and Sahitya Biswas, a student in the Translational Biology, Medicine, and Health Graduate Program, Pickrell was able to evaluate Leigh syndrome symptoms in a mouse model.
In their study, the researchers observed developmental defects and sluggish activity within specialized neural stem cells soon after birth.
They identified a malformed area centered on a bundle of nerve fibers called the corpus callosum, which is Latin for “tough body.” Using microscopy, researchers found a pattern of bad connections in this thick nerve tract that serves as the main line of communication between the left- and right-sides of the brain.
“From the data we’ve been collecting, it looks like it's just not developing the way it should,” Pickrell said. “The neural stem cells aren’t generating the types of cells they are supposed to.”
But now that they know where to look, there’s a path toward identifying children who suffer from Leigh Ssndrome earlier and getting them into clinical trials.
Original study DOI 10.1038/s44321-025-00367-4
END
Research findings may lead to earlier diagnoses of genetic disorder
2026-01-27
ELSE PRESS RELEASES FROM THIS DATE:
In polar regions, microbes are influencing climate change as frozen ecosystems thaw, McGill review finds
2026-01-27
Microbes across Earth’s coldest regions are becoming more active as glaciers, permafrost and sea ice thaw, accelerating carbon release and potentially amplifying climate change, according to a new international review from McGill University.
Drawing on data from polar and alpine environments worldwide, the researchers found that warming is driving faster microbial metabolism, increasing the breakdown of organic matter and the release of greenhouse gases such as carbon dioxide and methane into the ...
The Vertebrate Genome Laboratory at The Rockefeller University receives support from Google.org for AI science research
2026-01-27
NEW YORK, NY– Today, the Vertebrate Genome Laboratory, led by Erich Jarvis and Co-Directors Giulio Formenti and Jennifer Balacco, at The Rockefeller University, has received funding as part of Google.org's $20 million AI for Science Fund to support organizations focused on cutting-edge AI for science research. The funding has been awarded to twelve academic and nonprofit organizations around the world that are using AI to address increasingly complex problems at the intersections of various disciplines of science. The proportion ...
Scientists develop first gene-editing treatment for skin conditions
2026-01-27
Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the University of British Columbia are extending those possibilities to the skin for the first time.
The UBC team, together with researchers from the Berlin Institute of Health at Charité in Germany, has developed the first gene therapy capable of correcting faulty genes when applied directly to human skin. Outlined today in a paper published in Cell Stem Cell, the breakthrough could lead ...
New cancer-killing material developed by Oregon State University nanomedicine researchers
2026-01-27
PORTLAND, Ore. – Scientists at Oregon State University have developed a new nanomaterial that triggers a pair of chemical reactions inside cancer cells, killing the cells via oxidative stress while leaving healthy tissues alone.
The study led by Oleh and Olena Taratula and Chao Wang of the OSU College of Pharmacy was published this week in Advanced Functional Materials.
The findings advance the field of chemodynamic therapy or CDT, an emerging treatment approach based on the distinctive biochemical environment found in ...
Physicists predict significant growth for cadmium telluride photovoltaics
2026-01-27
A solar energy generation technology once considered limited in its potential is poised for significant growth in the United States.
That’s the conclusion of a team of scientists who analyzed the outlook for cadmium telluride photovoltaics in research published in the peer-reviewed journal Joule.
University of Toledo physicists including Dr. Michael Heben, a Distinguished University Professor and McMaster Chair and Director of the Wright Center for Photovoltaics Innovation and Commercialization, collaborated with partners at the U.S. Department of Energy’s National Laboratory ...
Purdue team announces new therapeutic target for breast cancer
2026-01-27
WEST LAFAYETTE, Ind. — A Purdue University team led by Kyle Cottrell has discovered a new therapeutic target for triple-negative breast cancer.
“Triple-negative breast cancer is a particularly deadly form of breast cancer that currently lacks targeted therapies,” said Cottrell, an assistant professor of biochemistry. Cottrell, biochemistry graduate student Addison Young and their co-authors describe the discovery in the journal RNA.
The laboratory research spotlights double-stranded ribonucleic acid (dsRNA)-binding proteins. ...
‘Nudging’ both patients and providers boosts flu vaccine numbers
2026-01-27
PHILADELPPHIA—Patients were 28 percent more likely to get a flu shot when they got a text message reminder and their primary care provider already had an order for the shot waiting, new research from the Perelman School of Medicine showed. The study was published in JAMA Internal Medicine.
“This is important given the rise in vaccine hesitancy, which has resulted in a downward trend in flu vaccination that coincided with a high rate of hospitalization this flu season,” said the study’s lead author, Shivan Mehta, MD, MBA, MSHP, associate chief innovation officer at Penn Medicine. “Many nudge interventions directed to patients only on vaccinations have shown ...
How do nature and nurture shape our immune cells?
2026-01-27
LA JOLLA (January 27, 2026)—The COVID-19 pandemic gave us tremendous perspective on how wildly symptoms and outcomes can vary between patients experiencing the same infection. How can two people infected by the same pathogen have such different responses?
It largely comes down to variability in genetics (the genes you inherit) and life experience (your environmental, infection, and vaccination history). These two influences are imprinted on our cells through small molecular alterations called epigenetic changes, which shape cell identity ...
Speeding, hard braking reduced in insurance plans that base rates on driving behavior, offer rewards
2026-01-27
Drivers whose car insurance rates are based on data of their driving habits and who then also got tips about improving them were less likely to speed, brake hard, or rapidly accelerate than those who didn’t participate in the program, according to a recent test by a team from the Perelman School of Medicine at the University of Pennsylvania. Their work was published in Accident Analysis & Prevention.
Speeding declined by up to 13 percent, and hard braking and rapid acceleration declined by up to 25 percent. In addition, drivers ...
Shared process underlies oral cancer pain and opioid tolerance
2026-01-27
Epidermal growth factor receptor (EGFR) signaling in the tissue around oral cancers both increases nerve sensitivity and makes opioids less effective, according to new research published in Science Signaling.
The findings point to a shared mechanism underlying both oral cancer pain and opioid tolerance—and a possible new treatment strategy for both.
“Repurposing existing cancer drugs that block EGFR may be a promising way to manage oral cancer pain and prevent or reverse opioid tolerance,” said Yi Ye, PhD, associate professor at NYU College of Dentistry and associate ...